Digitalization Lead, MES/ SAP
Boost your chances before you apply.
WuXi AppTec
Middletown, DE, US
Summary
The Digitalization Lead will spearhead the digital transformation roadmap by managing the end-to-end implementation and integration of ERP, LIMS, and MES systems. They will ensure all digital solutions maintain strict compliance with FDA, GMP, and data integrity standards while coordinating across global and local teams.
Job Description
Overview
We are seeking a high-energy, results-driven Digitalization Lead to spearhead the digital transformation roadmap at our Middletown manufacturing site. In this role, you will actively drive the end-to-end implementation, integration, and optimization of core enterprise and shop-floor systems, including ERP, LIMS, and MES. Serving as a critical bridge between local operations and global teams, you will deploy technical solutions that maximize operational efficiency while strictly maintaining FDA compliance, GMP validation, and data integrity standards. The ideal candidate brings a heavy blend of IT technical expertise and rigorous project management execution, backed by professional bilingual fluency in both English and Chinese to seamlessly coordinate across international boundaries.
Responsibilities
- Develop site digitalization roadmap, focusing on integration of ERP, LIMS, MES, etc.
- Lead & manage end-to-end ERP (e.g., SAP/Oracle) implementation, upgrade, and maintenance, ensuring pharmaceutical compliance.
- Lead & manage end-to-end manufacturing execution and operation management system (e.g., MES/WMS) implementation, upgrade, and maintenance, ensuring pharmaceutical compliance.
- Collaborate across IT, Manufacturing, Quality, and Supply Chain to organize resources for project management & execution.
- Ensure digital solutions comply with FDA/EMA data integrity principles (ALCOA+) and computer system validation (CSV) under GxP/GMP standards.
- Manage multiple projects with accountability for budget, timeline, risk mitigation, and milestone delivery.
- Establish project governance structures, reporting progress regularly to site leadership or steering committees.
Qualifications
- Bachelor’s/Master’s in Computer Science, IT, or related field.
- 5+ years of digital project management experience specifically within a pharmaceutical manufacturing, biotech, or CDMO environment with deep knowledge of GMP/GxP.
- 3+ years of hands-on experience in large-scale ERP system implementations (e.g., SAP, Oracle), with a strong grasp of manufacturing and supply chain modules.
- Deep understanding of pharmaceutical regulatory frameworks, including Current Good Manufacturing Practices (cGMP), 21 CFR Part 11
- Proven organizational skills in managing cross-functional teams and vendors.
- Strong project management capability; PMP/Prince2 certification preferred.
- Native or professional fluency in English is required; Mandarin is a plus, to effectively coordinate with global teams and stakeholders.
- Experience in multinational pharma or CDMO manufacturing sites preferred.
- Knowledge of drug discovery and pharmaceutical process development processes preferred.
An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability
This job description does not state or imply that the above are the only duties and responsibilities assigned to this position. Employees holding this position will be required to perform any other job-related duties as requested by Management.
Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services.
WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.
药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。
十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。
从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。
Company size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Org type
Privately Held
Headquarters
Shanghai
Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
WuXi AppTec has successfully established a fully integrated services and technology platform during the past decade. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services.
WuXi AppTec has developed from four founders and a single laboratory in December 2000 to 10,000 employees and 5 million square feet of laboratory and manufacturing space, including facilities under construction. The company is actively improving its capabilities and capacity through new expansions in its global business. Capitalizing on the great advantage of conducting R&D services both in China and in the U.S., WuXi AppTec is building an alternative R&D engine to serve the global life-science industry.
药明康德新药开发有限公司于2000年12月成立,是全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台公司,在中美两国均有运营实体。
十多年来,药明康德成功打造了全方位一体化的研发服务技术平台。创建之初,药明康德凭借其在发现化学合成领域的雄厚实力实现了全面发展。近几年来,我们又新增了一系列一体化服务,包括分析服务、生物分析服务、工艺研究、工艺研发服务、API生产服务、药物代谢及其动力学服务、研发生物学、药理学、制剂、毒理学、基因组服务、生物制剂生产服务、抗体及生物诊断试剂的生产和销售服务以及临床研发和产品注册服务等。
从 2000 年 12 月创立至今,药明康德的员工数从4 人增长至 10000 人,实验室由当初仅有的一间增长到近46 万平方米已有及在建研发基地和生产厂房。与此同时,药明康德还在不断增强服务能力,拓宽服务领域,以更好地服务公司持续增长的全球业务需求。作为一家全球领先的医药研发服务公司,药明康德将继续致力于在中美两国为全球客户提供高质量的医药研发服务,帮助研发出更多造福患者的新药及产品。
Company size
10,001+ employees
Industry
Pharmaceutical Manufacturing
Org type
Privately Held
Headquarters
Shanghai